Vaccines, Blood & Biologics
-
?
-
Biologics Post-Market Activities
FDA continues to assure product safety and efficacy even after a product is approved. These post-market activities include lot release (for some products), post-marketing adverse event reporting, and post-marketing study commitments (also known as Phase IV studies).
?
-
-